Genomics, proteomics: what’s next?

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.3, Iss.6, 2002-11, pp. : 727-728

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Technology: methodologies in genomics and proteomics

By Jon T. John M. Chris M.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Genomics and Proteomics of Nucleoside Transporters

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-01 ,pp. : 281-287

Bentham Science Publishers

Access to resources Recommend Favorite

Companies Applying Genomics and Proteomics to Cancer

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 1, 2003-01 ,pp. : 60-63

Adis International

Access to resources Recommend Favorite

Managing core resources for genomics and proteomics

By Apweiler Rolf Martin Maria Jesus O’Donovan Claire Pruess Manuela

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 343-350

Future Medicine

Access to resources Recommend Favorite

Harnessing the Power of Genomics and Proteomics - Part 2: Profiling Proteomics

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 1, 2003-01 ,pp. : 3-14

Adis International

Access to resources Recommend Favorite